March 11, 2008 - Sorin Group's ELA Medical received the FDA’s approval to market ISOLINE, a new defibrillation lead designed with redundant insulation and abrasion resistant materials for longevity and safety, in a move that strengthens the company’s position in the U.S. market.

March 10, 2008 - The FDA gave Siemens 510(k) market clearance of four new software applications used with the SOMATOM Definition aimed at simplifying the diagnosis of diseases of the heart, brain, lungs and extremity joints, as announced at ECR 2008, currently being held in Vienna.

March 7, 2008 – An individual’s physical health, psychological stress, social support and own sense of well-being, are all factors that can play a significant role in the likelihood of surviving an arrhythmic event, according to a study published in the March 2008 edition of the HeartRhythm Journal, the official journal of the Heart Rhythm Society.

March 7, 2008 – CircuLite has advanced its Synergy Pocket Circulatory Assist Device clinical program into a 20-patient trial, after completion of a first-in-man pilot study of Synergy in four patients, as the company seeks CE Mark approval in the European Union for long-term implantation of Synergy in heart failure patients.